January 13, 2021
Sosei Group and UK PharmEnable said on January 12 that they have formed a technology collaboration to carry out AI-powered drug discovery against a challenging G protein-coupled receptor (GPCR) target associated with neurological disorders. Through the deal, they will capitalize...read more